The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
1
|
B | Blood and blood forming organs | |
2
|
B03 | Antianemic preparations | |
3
|
B03A | Iron preparations | |
4
|
B03AB | Iron trivalent, oral preparations | |
5
|
B03AB05 | Ferric oxide polymaltose complexes |
| Active Ingredient |
|---|
|
The iron complex ferric carboxymaltose is designed to provide, in a controlled way, utilisable iron for the iron transport and storage proteins in the body (transferrin and ferritin, respectively). Ferric carboxymaltose treatment results in an increase in reticulocyte count, serum ferritin levels and TSAT levels to within normal ranges. |
|
|
| Document | Type | Information Source | |
|---|---|---|---|
| FERINJECT Solution for injection/infusion | MPI, EU: SmPC | Medicines & Healthcare Products Regulatory Agency (GB) |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.